Article
Engineered cells as glioblastoma therapeutics
22 Mar 2021
Abstract excerpt
In spite of significant recent advances in our understanding of the genetics and cell biology of glioblastoma, to date, this has not led to improved treatments for this cancer. In addition to small molecule, antibody, and engineered virus approaches, engineered cells are also being explored as glioblastoma therapeutics. This includes CAR-T cells, CAR-NK cells, as well as engineered neural stem cells and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
